<乌鸦传媒>Complications Common in Excision of Retained Cervix After Hysterectomy Occur in almost 40% of procedures, cancer in 18% of cases Apr 09, 2021
<乌鸦传媒>Ethics Consult: Stop Treatment for Costly Patient? MD/JD Weighs In You voted, now see the results and an expert's discussion Apr 09, 2021
<乌鸦传媒>Can a COX-2 Inhibitor Boost Disease-free Survival in CRC? Large trial tested addition of the agent to standard FOLFOX Apr 06, 2021
<乌鸦传媒>No Cancer Risk With Commonly Used Blood Pressure Meds Largest analysis yet but definitive data remain elusive Apr 05, 2021
<乌鸦传媒>Anti-PD-L1 Flops in Locally Advanced Head and Neck Cancer No PFS benefit from adding avelumab to chemoradiation, hazard ratio favored placebo Apr 02, 2021
<乌鸦传媒>A Win for Adjuvant Immunotherapy in Esophageal Cancer And other highlights from the Society of Surgical Oncology's virtual 2021 meeting Mar 31, 2021
<乌鸦传媒>Triage System Gets High Marks for Ovarian Cancer Debulking Surgery Key factors predicted threefold higher risk of 90-day mortality with primary surgery Mar 26, 2021
<乌鸦传媒>HIPEC Combo Doubles PFS in Advanced Ovarian Cancer Cisplatin/paclitaxel boosts outcomes without increasing complications in registry study Mar 26, 2021
<乌鸦传媒>Combo Tx Active in Recurrent, Platinum-Resistant Ovarian Cancer Ixabepilone plus bevacizumab yielded responses in a third of patients Mar 26, 2021
<乌鸦传媒>Vaccines and Rare Clotting Disorders: What's the Link? Causal relation appears possible, but evidence still indicates it's extremely rare Mar 25, 2021
<乌鸦传媒>Model: Give COVID-19 Vaccine to All Patients Before Surgery Prioritizing surgical patient population could avert more COVID deaths Mar 25, 2021
<乌鸦传媒>Marrow Cell Stimulator to Treat Alzheimer's Disease? Unusual approach pans out in mid-stage trial Mar 24, 2021
<乌鸦传媒>Op-Ed: Blood Cancer Patients Need More COVID Vax Answers Patients are left wondering, "will I be protected?" Mar 24, 2021
<乌鸦传媒>Safety Reassurance for Major Class of Diabetes Drugs Pooled trial data show no link to breast cancer Mar 24, 2021
<乌鸦传媒>Little Benefit With Adjuvant Therapy for High-Risk Endometrial Cancer Chemo prevented relapse but did not improve survival, no benefit from radiotherapy Mar 23, 2021
<乌鸦传媒>Androgen Receptor Inhibitor Active in Endometrial Cancer SGO: Apatinib for platinum-resistant ovarian cancer, pembrolizumab for advanced vulvar cancer Mar 22, 2021
<乌鸦传媒>Hormonal IUD Shows Promise in Early Endometrial Cancer Regression seen in 82% of women with precancerous lesions Mar 21, 2021
<乌鸦传媒>Small Molecule Inhibitor Shows Promise in Resistant Ovarian Cancer Responses in 37% of patients with AVB-500, higher without prior bevacizumab Mar 21, 2021
<乌鸦传媒>Op-Ed: Primary Care and Specialty Ping Pong Let's put an end to bureaucratic medicine and treat the patient in front of us Mar 21, 2021
<乌鸦传媒>Is MIS Viable for Interval Debulking in Ovarian Cancer? Retrospective study compared approach versus open surgery after neoadjuvant chemotherapy Mar 21, 2021
<乌鸦传媒>PARP Inhibitor Tops Chemo for Recurrent BRCA Ovarian Cancer Modest improvement in PFS with rucaparib but worse outcome for reversion mutation Mar 20, 2021
<乌鸦传媒>Practice-Changing Trial in Second-Line Endometrial Cancer Pembrolizumab plus lenvatinib improved median OS by nearly 7 months versus chemotherapy Mar 19, 2021
<乌鸦传媒>Class of Cancer Drug Linked to Aneurysms, Artery Dissections Database analysis finds more reports than expected with antiangiogenic drugs Mar 18, 2021
<乌鸦传媒>Acupuncture Tops Usual Care for Pain in Cancer Survivors Two types of acupuncture proved superior, with one better than the other Mar 18, 2021
<乌鸦传媒>C3 Inhibitor Prevails in Trial of Rare Hemoglobinuria Improvement in hemoglobin, transfusion independence with pegcetacoplan for PNH Mar 17, 2021
<乌鸦传媒>Time to Revisit Distant Nodal Status in Breast Cancer Curability? Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
<乌鸦传媒>Holding tPA for All DOAC Users Not the Way to Go, Stroke Docs Say Clinical conundrum could be solved by a point-of-care DOAC test Mar 15, 2021
<乌鸦传媒>Whole-Genome Sequencing Makes a Case in Leukemia Study More actionable alterations detected in myeloid malignancies versus cytogenetics Mar 10, 2021
<乌鸦传媒>Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemia Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
<乌鸦传媒>New Guideline Lowers Age to Begin Colorectal Cancer Screening Update comes as incidence has doubled in people under 50 Mar 09, 2021
<乌鸦传媒>USPSTF Expands Lung Cancer Screening Criteria Lower age for starting, new definition of 'heavy smoker' double eligibility for screening Mar 09, 2021
<乌鸦传媒>PD-1 Inhibitor Falls Short in Triple-Negative Breast Cancer No survival benefit with pembrolizumab vs chemotherapy in second-, third-line treatment Mar 08, 2021
<乌鸦传媒>Entrectinib Impresses in Certain Lung Cancers Durable responses in most patients with advanced NSCLC, active in brain mets Mar 05, 2021
<乌鸦传媒>New Targeted Therapies Show Promise in Cancer Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
<乌鸦传媒>Mammo Study: One Saves Lives, More Exams Save More Lives Risk of fatal breast cancer decreases with increasing participation in screening Mar 02, 2021
<乌鸦传媒>Neoadjuvant Dual ICI Leads to Clinical Benefit in Operable NSCLC More than one-third of patients achieved major pathologic response with nivolumab-ipilimumab. Feb 18, 2021
<乌鸦传媒>A CLEAR Upfront Winner in Advanced RCC? Pembrolizumab-lenvatinib makes splash with longest PFS benefit in RCC recorded to date Feb 14, 2021
<乌鸦传媒>Practice-Changing Trial in Metastatic Papillary RCC Cabozantinib improved PFS, response rates over sunitinib Feb 14, 2021
<乌鸦传媒>New Standard in High-Risk Muscle-Invasive Bladder Cancer? Adjuvant nivolumab improves DFS in all comers, PD-L1 population Feb 13, 2021
